BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 20, 2001
View Archived Issues
Therapeutic efficacy of 6R-BH4 in autism
Read More
Shire highlights Q3 developments and updates product pipeline
Read More
Supratek initiates enrollment for SP-1049C phase II trial
Read More
Research collaboration targets proteins related to muscular dystrophy and neurodegenerative diseases
Read More
NicVAX nicotine vaccine completes preclinical safety testing
Read More
Investigational cancer drug GS-7836 moves to phase I testing
Read More
Development of SMART antibody for Crohn's disease continues based on preliminary findings
Read More
E.U. approval of Protopic recommended by CPMP
Read More
Launch of Xalcom/Xalacom begins in Europe
Read More
PhotoCure reports preliminary results from phase III trial of Metvix in basal cell carcinoma
Read More
AASLD news: Ceplene-containing combination therapies effective in hepatitis C
Read More
Adolor highlights Q3 clinical trial progress
Read More
Sustained antiviral effect, good safety of Coviracil in chronic HBV seen in 48-week phase I trial
Read More
Novuspharma updates R&D activities
Read More
Research and clinical programs continue to advance at Photogen
Read More
Clevudine exerts potent anti-HBV activity in early clinical trial
Read More
CTLA4Ig and LEA29Y demonstrate clinical and biological activity in RA
Read More
Major approval obtained by Pharmacia/Pfizer for new antiinflammatory/analgesic
Read More
Pexelizumab advances to pivotal trials in CABG/CPB patients; phase IIb data discussed at AHA
Read More
Antisense compounds designed at Isis targeting the ADAM10 gene
Read More
DNA encoding human acid-sensing ion channel cloned and characterized at Ortho-McNeil
Read More
Japan Tobacco claims new compounds potentiating neurite outgrowth
Read More
Novel series in development by Merck and Banyu has potential for diabetes, obesity, etc.
Read More
Inhibitors of P-450RAI as an approach to psoriasis and other retinoid-responsive disorders
Read More
P&G patents new MMP inhibitors useful for rheumatoid arthritis, osteoarthritis and cancer
Read More
Japanese lab presents new Rho kinase-inhibitory amides
Read More